about
Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort studyReady for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action.Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenesCommunity-associated methicillin-resistant Staphylococcus aureus, SwitzerlandShould this event be notified to the World Health Organization? Reliability of the international health regulations notification assessment processMolecular and epidemiological evaluation of strain replacement in patients previously harboring gentamicin-resistant MRSAThe PIRO concept: R is for responseG-CSF and IL-8 for early diagnosis of sepsis in neonates and critically ill children - safety and cost effectiveness of a new laboratory prediction model: study protocol of a randomized controlled trial [ISRCTN91123847].Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team?Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-AnalysisComparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysisBench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative reviewOutpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspectiveComparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trialPrevention and Control of Methicillin-Resistant Staphylococcus aureus in Acute Care Settings.Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum.Priority actions to fight antibiotic resistance: results of an international meetingAn in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia."Antibiotics are not automatic anymore"--the French national campaign to cut antibiotic overuse.Linking Sustainable Use Policies to Novel Economic Incentives to Stimulate Antibiotic Research and Development.Multilevel competing risk models to evaluate the risk of nosocomial infection.Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study.Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance.Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates.[Urinary tract infections in adults].Clostridium: transmission difficile?Low risk despite high endemicity of methicillin-resistant Staphylococcus aureus infections following elective total joint arthroplasty: a 12-year experience.Bacteremic sepsis in intensive care: temporal trends in incidence, organ dysfunction, and prognosis.Society's failure to protect a precious resource: antibiotics.Acute respiratory distress syndrome after bacteremic sepsis does not increase mortality.Use of benchmarking and public reporting for infection control in four high-income countries.Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study.Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus.Cost implications of successful hand hygiene promotion.The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
P50
Q21195056-DCB6169E-DE09-4B55-B795-6960B2596BC4Q21195823-FA390DDD-613C-45A4-B4AC-67883E99D713Q24600215-C0F0EE58-57CA-46A2-B7E7-A71029B8AA02Q24611394-05B9BE47-07B6-44F2-9127-E7F6A5D71D59Q24630271-E3ECE32D-2AB3-4E73-8314-D1711A590F7FQ24631371-65502FF3-3851-43DD-AD89-16E7E5F290F2Q24795268-C01FF48D-496F-4115-9AFA-821B354B7239Q24801380-9A03F349-CEFE-4943-8DE3-E955D7CDDF92Q24802589-9CC59B5D-65A9-4904-B28E-2C48DECE57D9Q26774000-BFF88519-A638-470E-BCD3-C59FC6ED469EQ26798293-CA4D1F31-09C8-40AB-A05E-745E607A3184Q27003122-907BE558-EB14-4214-9E08-CE0BA61AE877Q28033223-35126F0C-F7CF-423D-B907-BA92336CB299Q28069165-C347365A-0226-4A51-82DC-B975478CC656Q28194501-DA6CA25E-3A3C-401A-A0CF-4610AD9C45D6Q28680123-2E2DE7C2-FABF-44B4-831D-B8BACC6F7736Q30241764-28C460A5-0148-48F0-9127-4E86032585CEQ30391042-52B8921F-8604-41D5-B1A9-9FE9581E3E89Q30394856-9E756E76-E7C3-41C1-AF58-8E8C48EE70FBQ30603772-8945D4F5-F116-482E-80E2-EAE73711C26FQ33276665-96E8EE99-BA7D-4914-916C-BA4D6E34F165Q33459227-88F4A083-6E64-4D97-909C-C6A8AB75851AQ33564293-36D02B14-76B5-4C28-AEAA-BC65D880058BQ33750199-DFB1BF19-18D1-40CA-B832-EEC1E7BE9F39Q33754099-2F6C871E-7151-473B-9B4C-68872B5877E6Q33843533-415111F2-C98D-43A4-BE80-A7AA92346E59Q33883793-82E49AAA-7245-4DA7-B730-155A7C1BAF00Q33885060-837E8FC6-D05C-4F6A-B9DC-5F775C70A9D3Q34027326-9097A547-6E2E-4659-85AF-0BF50FE2A23AQ34162219-A03CEED1-6294-4641-8ED8-A2FCA4133002Q34166902-10CD7D28-FF39-46D3-A722-365F1364528CQ34176227-502771E9-A54D-4F3C-8080-87D36A6F2444Q34176981-6CF8A3D4-DFE8-445A-9CDE-5DFB4BD3FED5Q34181010-F2D03584-2D75-4ABB-B798-6D99535D3130Q34187572-CDC8E794-2C63-44EE-9BA3-FE267F06A8F0Q34188681-022D26DD-A826-41A7-B815-2AA195243D12Q34274614-4AC90121-66AB-4900-8BCF-C30E134761BAQ34298209-88B058BB-4D23-4F7A-81FB-278D3A4D851EQ34310744-0C850968-7BC4-4127-8499-E1538C44223CQ34401421-604D9B2B-0733-409E-82EC-CD47EC1221DB
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Stephan Harbarth
@ast
Stephan Harbarth
@en
Stephan Harbarth
@es
Stephan Harbarth
@nl
type
label
Stephan Harbarth
@ast
Stephan Harbarth
@en
Stephan Harbarth
@es
Stephan Harbarth
@nl
prefLabel
Stephan Harbarth
@ast
Stephan Harbarth
@en
Stephan Harbarth
@es
Stephan Harbarth
@nl
P106
P21
P214
7216150567630606370007
P31
P496
0000-0002-3551-1025
P7859
viaf-7216150567630606370007